PubRank

Yudi Pawitan

Author PubWeight™ 129.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 2005 13.54
2 Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009 12.96
3 Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006 8.08
4 Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst 2008 3.55
5 Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet 2013 3.25
6 Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res 2006 2.69
7 An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A 2008 2.64
8 Revisiting Mendelian disorders through exome sequencing. Hum Genet 2011 2.57
9 Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 2010 2.40
10 Strategies and issues in the detection of pathway enrichment in genome-wide association studies. Hum Genet 2009 2.31
11 The pursuit of genome-wide association studies: where are we now? J Hum Genet 2010 2.28
12 Parental age and risk of childhood cancers: a population-based cohort study from Sweden. Int J Epidemiol 2006 2.22
13 Correlation test to assess low-level processing of high-density oligonucleotide microarray data. BMC Bioinformatics 2005 1.86
14 Statistical challenges associated with detecting copy number variations with next-generation sequencing. Bioinformatics 2012 1.70
15 Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data. Bioinformatics 2011 1.69
16 Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 2004 1.52
17 Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol 2005 1.49
18 Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination. Cancer Biol Ther 2008 1.48
19 Improved grading of breast adenocarcinomas based on genomic instability. Cancer Res 2004 1.47
20 Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 2005 1.45
21 Importance of familial factors in associations between offspring birth weight and parental risk of type-2 diabetes. Int J Epidemiol 2007 1.44
22 Normalization of oligonucleotide arrays based on the least-variant set of genes. BMC Bioinformatics 2008 1.41
23 mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol 2011 1.40
24 Multidimensional local false discovery rate for microarray studies. Bioinformatics 2005 1.39
25 Maternal effects for preterm birth: a genetic epidemiologic study of 630,000 families. Am J Epidemiol 2009 1.34
26 Regions of homozygosity and their impact on complex diseases and traits. Hum Genet 2010 1.30
27 Covariance component models for multivariate binary traits in family data analysis. Stat Med 2008 1.27
28 Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort. Cancer Epidemiol Biomarkers Prev 2008 1.26
29 Network enrichment analysis: extension of gene-set enrichment analysis to gene networks. BMC Bioinformatics 2012 1.24
30 Genetic and shared environmental factors do not confound the association between birth weight and hypertension: a study among Swedish twins. Circulation 2007 1.23
31 Identification of differentially expressed genes and false discovery rate in microarray studies. Curr Opin Lipidol 2007 1.22
32 Familial aggregation of small-for-gestational-age births: the importance of fetal genetic effects. Am J Obstet Gynecol 2006 1.17
33 Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden. Cancer Res 2007 1.17
34 The discovery of human genetic variations and their use as disease markers: past, present and future. J Hum Genet 2010 1.17
35 Super-sparse principal component analyses for high-throughput genomic data. BMC Bioinformatics 2010 1.16
36 Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. Cancer Epidemiol Biomarkers Prev 2008 1.13
37 Filtering genes to improve sensitivity in oligonucleotide microarray data analysis. Nucleic Acids Res 2007 1.12
38 Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Med 2006 1.08
39 Heritability, assortative mating and gender differences in violent crime: results from a total population sample using twin, adoption, and sibling models. Behav Genet 2011 1.08
40 Validation of a radiosensitivity molecular signature in breast cancer. Clin Cancer Res 2012 1.02
41 Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X. Mod Pathol 2012 1.01
42 Robust smooth segmentation approach for array CGH data analysis. Bioinformatics 2007 1.00
43 Integrated molecular portrait of non-small cell lung cancers. BMC Med Genomics 2013 0.99
44 The association between low birth weight and type 2 diabetes: contribution of genetic factors. Epidemiology 2008 0.98
45 Human genetics and genomics a decade after the release of the draft sequence of the human genome. Hum Genomics 2011 0.95
46 Genomic instability and prognosis in breast carcinomas. Cancer Epidemiol Biomarkers Prev 2006 0.94
47 Modified least-variant set normalization for miRNA microarray. RNA 2010 0.93
48 Genomic copy number variations in three Southeast Asian populations. Hum Mutat 2010 0.92
49 Robust ascertainment-adjusted parameter estimation. Genet Epidemiol 2005 0.90
50 Joint estimation of isoform expression and isoform-specific read distribution using multisample RNA-Seq data. Bioinformatics 2013 0.90
51 Exome versus transcriptome sequencing in identifying coding region variants. Expert Rev Mol Diagn 2012 0.90
52 Advancing paternal age and offspring violent offending: a sibling-comparison study. Dev Psychopathol 2012 0.89
53 Is the association between general cognitive ability and violent crime caused by family-level confounders? PLoS One 2012 0.89
54 Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia. J Proteome Res 2008 0.88
55 Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism. J Proteome Res 2013 0.88
56 Case-cohort methods for survival data on families from routine registers. Stat Med 2008 0.88
57 Technological advances in DNA sequence enrichment and sequencing for germline genetic diagnosis. Expert Rev Mol Diagn 2012 0.87
58 Correlating gene and protein expression data using Correlated Factor Analysis. BMC Bioinformatics 2009 0.87
59 Fold-change estimation of differentially expressed genes using mixture mixed-model. Stat Appl Genet Mol Biol 2005 0.86
60 Genetic mixed linear models for twin survival data. Behav Genet 2007 0.86
61 A genome-wide assessment of variability in human serum metabolism. Hum Mutat 2013 0.86
62 Tobacco use, body mass index and the risk of malignant lymphomas--a nationwide cohort study in Sweden. Int J Cancer 2006 0.86
63 Identification of recurrent regions of Copy-Number Variants across multiple individuals. BMC Bioinformatics 2010 0.85
64 Between-within models for survival analysis. Stat Med 2013 0.84
65 Unequal group variances in microarray data analyses. Bioinformatics 2008 0.84
66 Incidence, mortality and survival patterns of prostate cancer among residents in Singapore from 1968 to 2002. BMC Cancer 2008 0.83
67 Bounds on sufficient-cause interaction. Eur J Epidemiol 2014 0.82
68 Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden. BMC Cancer 2014 0.82
69 Normalization of gene-expression microarray data. Methods Mol Biol 2010 0.82
70 A population-based study of copy number variants and regions of homozygosity in healthy Swedish individuals. J Hum Genet 2011 0.81
71 Multi-platform segmentation for joint detection of copy number variants. Bioinformatics 2011 0.81
72 Etiology of familial aggregation in melanoma and squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 2007 0.80
73 Regions of homozygosity in three Southeast Asian populations. J Hum Genet 2011 0.79
74 Annotated regions of significance of SELDI-TOF-MS spectra for detecting protein biomarkers. Proteomics 2006 0.79
75 Finding regions of significance in SELDI measurements for identifying protein biomarkers. Bioinformatics 2006 0.79
76 Detecting differential expression in microarray data: comparison of optimal procedures. BMC Bioinformatics 2007 0.78
77 Rediscovery rate estimation for assessing the validation of significant findings in high-throughput studies. Brief Bioinform 2014 0.78
78 Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes. Genes Chromosomes Cancer 2007 0.77
79 Partial least squares and logistic regression random-effects estimates for gene selection in supervised classification of gene expression data. J Biomed Inform 2013 0.76
80 Modelling infectious disease transmission with complex exposure pattern and sparse outcome data. Stat Med 2004 0.75
81 Svensson et al. respond to "Maternal genes and environment in preterm birth". Am J Epidemiol 2009 0.75
82 Verifying elimination programs with a special emphasis on cysticercosis endpoints and postelimination surveillance. J Parasitol Res 2012 0.75
83 Matched ascertainment of informative families for complex genetic modelling. Behav Genet 2009 0.75
84 [Cancer researchers need statistical uncertainty!]. Lakartidningen 2004 0.75
85 Sparse partial least-squares regression for high-throughput survival data analysis. Stat Med 2013 0.75
86 Likelihood ratio and score burden tests for detecting disease-associated rare variants. Stat Appl Genet Mol Biol 2015 0.75
87 Classification of array CGH data using smoothed logistic regression model. Stat Med 2009 0.75
88 Genetic analysis of age-at-onset traits based on case-control family data. Stat Med 2010 0.75
89 Copy number polymorphisms in new HapMap III and Singapore populations. J Hum Genet 2011 0.75